Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

ViiV Healthcare discloses new anti-HIV compounds

Oct. 6, 2021

Shionogi licenses S-365598 to ViiV for use in ultra long-acting HIV regimens

Sep. 29, 2021

Selective functional impairment of HIV-specific CD8+ T cells heralds aborted HIV control

Sep. 28, 2021

New HIV replication inhibitors discovered at Gilead

Sep. 21, 2021

Pharmasyntez JSC identifies HIV-1 reverse transcriptase/ribonuclease H inhibitors

Sep. 16, 2021

Green light for UB-421 phase II studies in Taiwan and China for HIV

Aug. 19, 2021

Ghent University Hybrid CAR-T cell platform has dual anti-HIV effects

July 28, 2021

RNA-directed gene therapy targeting shPromA/shCCR5 tested in chronic HIV infection model

July 23, 2021

XPB shown to regulate HIV-1 transcriptional activity

July 22, 2021

IRF7 and PTDSS2 are therapeutic targets in HIV-1 infection

July 22, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...